SUBSCRIBE
SUBSCRIBE
News   Business

Pacific Biosciences Appoints Michael J. Glynn as Chief Commercial Officer

October 4, 2011 | 
1 min read
MENLO PARK, Calif.--(BUSINESS WIRE)--Pacific Biosciences of California, Inc. (NASDAQ: PACB), provider of Single Molecule Real Time (SMRT®) sequencing products, today announced the appointment of Michael J. Glynn as Chief Commercial Officer.
People
PacBio
MORE ON THIS TOPIC
Businessmen look at the city from the outskirts.
Pipeline
Moderna looks out to R&D ‘horizons’ as 2028 break-even goal looms
June 26, 2026
 · 
2 min read
 · 
Tristan Manalac
Big fish eats small, takeover of the company. Art collage.
M&A
Merck KGaA inks $11B Bio-Techne buyout to expand into cell therapy production
June 26, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Mold spray. Mold control specialist. Hand in glove sprays the product antifungal. Dangerous fungus to kill. Man cleans bathroom cleaning products. Vector illustration flat design.
Manufacturing
Jubilant draws FDA rebuke for delayed mold investigation and quality unit lapses
June 24, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Concept art for large layoffs showing a line of blocks a cliff
Layoffs
ADC Therapeutics lays off staff after 27 patient deaths mar Zynlonta readout
June 24, 2026
 · 
2 min read
 · 
Gabrielle Masson